CD20 is a transmembrane, non-glycosylated protein expressed on B-cell precursors andmature B cells, but is lost following differentiation into plasma cells. This antibody does notcross-react with non-hematopoetic neoplasms. CD20 (B-cell Pan) reacts with a membrane antigen that is present in B-cells. This antibody strongly recognizes Reed-Sternberg cells predominant in Hodgkin`s disease. Since no staining of histiocytes or plasma cells has been observed and CD20 has not been detected in T-cell malignancies, it is a very strong marker of B-cell lymphomas. B-cell, Panmarker recognizes a formalin resistant intracytoplasmic antigen
| Intended Use | IVD |
|---|---|
| Antibody Type | Monoclonal |
| Clone | CD20/C23 |
| Source | Mouse |
| Tissue Type/Cancer Type | Spleen |
| Pack | 0.5 mL – Manual – Concentrate, 1 mL – Manual – Concentrate, 6 mL – Manual – RTU, 50 Tests – Automation – Xmatrx, 100 Tests – Automation – i6000, 160 Tests – Automation – Xmatrx, 5 slides – Xmatrx, 5 slides – Manual |
